The Asia Pacific biopharma development and production industry is growing rapidly, and it continues to evolve. An increase in the adoption of innovative technology and investments in sophisticated R&D are driving this expansion. Game changes are aplenty, with 4.0 and regenerative medicine attracting investor interest.
The 5th Bioprocess & Technology incorporates the inaugural Cell and Gene Therapy and will address outlook, investment, process development, and technical innovation to keep participants at the forefront of the industry.
Still have a question?